PK

Priti Keshri

Active Director Director DIN 08850367
DIN 08850367 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Priti Keshri

Data last updated:

Priti Keshri is a Director at Emikaa Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Emikaa Pharmaceutical Private Limited reported revenue of ₹1.3 Lakh (FY 2020).

DIN 08850367
Primary Designation Director
Industry Pharma
First Appointment 04 Nov 2020
Oldest Company Age 7 yrs
Largest company Emikaa Pharmaceutical Private Limited · ₹1.3 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Nov 20202019₹1.3 Lakh (FY 2020)Active

Board colleagues of Priti Keshri

NameDINCompanyDesignation
Mohnish Kumar Nandeshwar08471755Emikaa Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Emikaa Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Priti Keshri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priti Keshri

Priti Keshri currently holds 1 directorship: Emikaa Pharmaceutical Private Limited (Director, since 04 Nov 2020, revenue ₹1.3 Lakh (FY 2020)).

Priti Keshri was first appointed on 04 Nov 2020 as Director at Emikaa Pharmaceutical Private Limited.

The current boards of Priti Keshri's companies include Mohnish Kumar Nandeshwar (Emikaa Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available